drugset / Trial / NCT01518920
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
RandomizedCrossoverTriple-blindTreatment
Summary
The objective of this study is to examine the safety, tolerability, and effects on hearing thresholds of two single doses of PF-04958242 and placebo in subjects with age-related hearing loss.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PESAMPATOR | Small molecule | 0.27 mg | Oral |
| Subject | PESAMPATOR | Small molecule | 0.35 mg | Oral |